logo

For the Inventor, By the Inventor

Frankfurt, Germany

Heinz Kuch

This inventor holds 3 USPTO granted patents. Top assignee: Hoechst Aktiengesellschaft. Active years: 1985-1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heinz Kuch. Retrieved from https://idiyas.com/inventor/heinz-kuch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Frankfurt-am-Main, DE (1985 - 1986)
  • Kelkheim, DE (1986)

Company Filing History:

goldMedal3 out of 6,705 
 
Hoechst Aktiengesellschaft
 patents

Years Active: 1985-1986

Loading Chart...
3 patents (USPTO):Explore Patents
1. 4624963 - Use of oxindole compounds for the treatment of epilepsy (1986-11-25),
2. 4614739 - Oxindole derivatives, pharmaceutical compositions and use (1986-09-30),
3. 4542148 - 2-Oxo-3-phenyl indole derivatives, drugs having a neuroanabolic action (1985-09-17),

Title: Innovations of Heinz Kuch in Epilepsy Treatment

Introduction

Heinz Kuch is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of epilepsy. With a total of 3 patents to his name, Kuch's work focuses on the development of oxindole compounds that have therapeutic potential.

Latest Patents

Kuch's latest patents include innovative uses of oxindole compounds for the treatment of epilepsy. One of his patents describes oxindole compounds of a specific formula, which are utilized for preparing medicaments aimed at treating epilepsy. Another patent details oxindole derivatives and their pharmaceutical compositions, highlighting their neuroanabolic action in various animal models. These advancements represent a significant step forward in epilepsy treatment.

Career Highlights

Heinz Kuch has had a distinguished career, working with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His research and inventions have contributed to the understanding and treatment of neurological disorders, particularly epilepsy.

Collaborations

Kuch has collaborated with Hansjorg Kruse, a fellow researcher, to further enhance the development of their innovative compounds. Their partnership has been instrumental in advancing their research efforts.

Conclusion

Heinz Kuch's contributions to the field of epilepsy treatment through his innovative patents demonstrate his commitment to improving medical therapies. His work continues to pave the way for new treatments that can significantly impact patients' lives.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…